相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Risk factors for gastric cancer: is it time to discard PPIs?
Lucrezia Laterza et al.
GUT (2019)
Helicobacter pylori eradication failure may have confounded the recent large-scale health database study that showed proton pump inhibitors increase gastric cancer risk
Hidekazu Suzuki et al.
GUT (2018)
Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study
Ka Shing Cheung et al.
GUT (2018)
Proton-pump inhibitors and increased gastric cancer risk: time-related biases
Samy Suissa et al.
GUT (2018)
Proton pump inhibitors (PPIs) may cause gastric cancer - clinical consequences
Helge L. Waldum et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2018)
Inhibition of STAT3 in gastric cancer: role of pantoprazole as SHP-1 inducer
Jin Sung Koh et al.
CELL AND BIOSCIENCE (2018)
Effects of proton pump inhibitors on reversing multidrug resistance via downregulating V-ATPases/PI3K/Akt/mTOR/HIF-1α signaling pathway through TSC 1/2 complex and Rheb in human gastric adenocarcinoma cells in vitro and in vivo
Min Chen et al.
ONCOTARGETS AND THERAPY (2018)
S1PR1 predicts patient survival and promotes chemotherapy drug resistance in gastric cancer cells through STAT3 constitutive activation
Shiyu Song et al.
EBIOMEDICINE (2018)
The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association
Daniel E. Freedberg et al.
GASTROENTEROLOGY (2017)
25 Years of Proton Pump Inhibitors: A Comprehensive Review
Daniel S. Strand et al.
GUT AND LIVER (2017)
Serum gastrin and cholecystokinin are associated with subsequent development of gastric cancer in a prospective cohort of Finnish smokers
Gwen Murphy et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2017)
Proton-pump inhibitors: understanding the complications and risks
Peter Malfertheiner et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance
Yuan-Yuan Xu et al.
ONCOTARGET (2017)
Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden
Nele Brusselaers et al.
BMJ OPEN (2017)
Targeted molecular ablation of cancer stem cells for curing gastrointestinal cancers
Yong Seok Kim et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2017)
Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use
Bryony N. Parsons et al.
PLOS PATHOGENS (2017)
Comparison of Endoscopic Submucosal Dissection and Surgery for Differentiated Type Early Gastric Cancer within the Expanded Criteria
Dong Woo Shin et al.
CLINICAL ENDOSCOPY (2017)
Targeting BMI1+ Cancer Stem Cells Overcomes Chemoresistance and Inhibits Metastases in Squamous Cell Carcinoma
Demeng Chen et al.
CELL STEM CELL (2017)
TNF-α-inducing protein of Helicobacter pylori induces epithelialmesenchymal transition (EMT) in gastric cancer cells through activation of IL-6/STAT3 signaling pathway
Guodong Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Epigenetic regulation and anti-tumorigenic effects of SH2-containing protein tyrosine phosphatase 1 (SHP1) in human gastric cancer cells
Moon Kyung Joo et al.
TUMOR BIOLOGY (2016)
Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis
An Tran-Duy et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial
Kazumasa Fujitani et al.
LANCET ONCOLOGY (2016)
PAI-1 deficiency increases the trophic effects of hypergastrinemia in the gastric corpus mucosa
Reidar Fossmark et al.
PEPTIDES (2016)
Proton Pump Inhibitors Display Antitumor Effects in Barrett's Adenocarcinoma Cells
Eduardo Chueca et al.
FRONTIERS IN PHARMACOLOGY (2016)
Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology
L. Lundell et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies
A. L. Wong et al.
ANNALS OF ONCOLOGY (2015)
Signal transducers and activators of transcription 3-induced metastatic potential in gastric cancer cells is enhanced by glycogen synthase kinase-3β
Jiyeon Yoon et al.
APMIS (2015)
Proton pump inhibitor pantoprazole abrogates adriamycin-resistant gastric cancer cell invasiveness via suppression of Akt/GSK-β/β-catenin signaling and epithelial-mesenchymal transition
Bin Zhang et al.
CANCER LETTERS (2015)
Acquisition of resistance to trastuzumab in gastric cancer cells is associated with activation of IL-6/STAT3/Jagged-1/Notch positive feedback loop
Zhengyan Yang et al.
ONCOTARGET (2015)
Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors
Do-Youn Oh et al.
CANCER RESEARCH AND TREATMENT (2015)
Gastrin May Mediate the Carcinogenic Effect of Helicobacter pylori Infection of the Stomach
Helge L. Waldum et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Bidirectional regulation between TMEFF2 and STAT3 may contribute to Helicobacter pylori-associated gastric carcinogenesis
Tian-Tian Sun et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
The fight against gastric cancer - the IARC Working Group report
Rolando Herrero et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2014)
STAT3 Mediates Regorafenib-Induced Apoptosis in Hepatocellular Carcinoma
Wei-Tien Tai et al.
CLINICAL CANCER RESEARCH (2014)
TMEFF2 Deregulation Contributes to Gastric Carcinogenesis and Indicates Poor Survival Outcome
Tiantian Sun et al.
CLINICAL CANCER RESEARCH (2014)
The PAS positive material in gastric cancer cells of signet ring type is not mucin
Oystein Sordal et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2014)
The IL-6-STAT3 axis mediates a reciprocal crosstalk between cancer-derived mesenchymal stem cells and neutrophils to synergistically prompt gastric cancer progression
Q. Zhu et al.
CELL DEATH & DISEASE (2014)
Feedback activation of STAT3 mediates trastuzumab resistance via upregulation of MUC1 and MUC4 expression
Guangchao Li et al.
ONCOTARGET (2014)
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Hua Yu et al.
NATURE REVIEWS CANCER (2014)
Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions
Huan Song et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells
Mi-Jung Kim et al.
CANCER LETTERS (2013)
Proton pump inhibitor selectively suppresses proliferation and restores the chemosensitivity of gastric cancer cells by inhibiting STAT3 signaling pathway
Shuling Huang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2013)
Effect of pantoprazole on human gastric adenocarcinoma SGC7901 cells through regulation of phospho-LRP6 expression in Wnt/β-catenin signaling
Weidong Shen et al.
ONCOLOGY REPORTS (2013)
STAT3 is associated with lymph node metastasis in gastric cancer
Jingyu Deng et al.
TUMOR BIOLOGY (2013)
Acid suppressive drugs and gastric cancer: A meta-analysis of observational studies
Jeong Soo Ahn et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Inhibition of activated Stat3 reverses drug resistance to chemotherapeutic agents in gastric cancer cells
Shuling Huang et al.
CANCER LETTERS (2012)
Dovitinib Induces Apoptosis and Overcomes Sorafenib Resistance in Hepatocellular Carcinoma through SHP-1-Mediated Inhibition of STAT3
Wei-Tien Tai et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Sorafenib Overcomes TRAIL Resistance of Hepatocellular Carcinoma Cells through the Inhibition of STAT3
Kuen-Feng Chen et al.
CLINICAL CANCER RESEARCH (2010)
Safety of Proton Pump Inhibitor Exposure
Yu-Xiao Yang et al.
GASTROENTEROLOGY (2010)
pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity
Angelo De Milito et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Calcium-sensing receptor is a physiologic multimodal chemosensor regulating gastric G-cell growth and gastrin secretion
Jianying Feng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
STAT-3 correlates with lymph node metastasis and cell survival in gastric cancer
Jing-Yu Deng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Proton pump inhibitors and risk of gastric cancer: a population-based cohort study
A. H. Poulsen et al.
BRITISH JOURNAL OF CANCER (2009)
Effects and mechanisms of proton pump inhibitors as a novel chemosensitizer on human gastric adenocarcinoma (SGC7901) cells
Min Chen et al.
CELL BIOLOGY INTERNATIONAL (2009)
Targeting STAT3 in cancer: how successful are we?
Pedbin Yue et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
STAT3 expression in gastric cancer indicates a poor prognosis
Dae-Young Kim et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Association between use of acid-suppressive drugs and risk of gastric cancer - A nested case-control study
Hani Tamim et al.
DRUG SAFETY (2008)
Helicobacter pylori infection and development of gastric cancer in Korea
Nayoung Kim et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2008)
Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK
L. A. Garcia Rodriguez et al.
GUT (2006)
Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma
Yajun Han et al.
BLOOD (2006)
High salt diets dose-dependently promote gastric chemical carcinogenesis in Helicobacter pylori-infected Mongolian gerbils associated with a shift in mucin production from glandular to surface mucous cells
Sosuke Kato et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis
Louise M. Judd et al.
GASTROENTEROLOGY (2006)
Signet ring cells in gastric carcinomas are derived from neuroendocrine cells
Karin Bakkelund et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2006)
Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial
L Lundell et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells
M Yeo et al.
CLINICAL CANCER RESEARCH (2004)
The function of the protein tyrosine phosphatase SHP-1 in cancer
CY Wu et al.
GENE (2003)
Activated proliferation of B-cell lymphomas/leukemias with the SHP1 gene silencing by aberrant CpG methylation
M Koyama et al.
LABORATORY INVESTIGATION (2003)
Medical progress:: Helicobacter pylori infection
S Suerbaum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
分享论文
